Mylan (MYL) Plans to Launch TLE400 for $99/Patient/Year in Developing Markets
Tweet Send to a Friend
Mylan (Nasdaq: MYL) announced that it expects to be the first to launch, upon regulatory approval and for developing country ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE